Nav: Home

Vulnerability to Ebola and Lassa fever can now be properly assessed

June 04, 2019

Identifying vulnerabilities to outbreaks of Ebola and Lassa fever is possible following new research from the University of Surrey and University of Cambridge. This will aid government agencies and health organisations in evaluating a country's vulnerability to outbreaks, and inform decisions on strategic investments and plans.

Vulnerability - an assessment of a country's ability or inability to resist a hazard or to respond when a disaster has occurred - is a well-established model in the field of climate change and natural disasters; however, in disease management it is a relatively undefined concept.

To assess this kind of vulnerability researchers developed a new methodology that - instead of focussing on the confirmed number of patients infected with the disease (impact) - monitors the number of survivors ('adaptive capacity'). A simple mathematical formula of impact versus adaptive capacity has been used to calculate a degree of vulnerability, which will help international bodies allocate resources.

To test their model researchers examined data from Lassa fever epidemics in Nigeria (2017 - 2018) and Sierra Leone (2008 - 2012) and Ebola in Sierra Leone (2013 - 2016). Using the methodology, researchers found that the most vulnerable states are not necessarily those with the highest number of confirmed cases; for instance, the state of Plateau in Nigeria was found to be the most vulnerable to Lassa fever despite the relatively low burden of the disease in the region.

Researchers also found that vulnerability can change during an outbreak. The vulnerability to Lassa fever in Nigeria decreased during of epidemics compared to the vulnerability for Sierra Leone that increased after 2010, indicating a rising number of deaths. The data available suggests a difficulty in coping with the disease in the region.

The next step is to investigate how vulnerability depends on relevant environmental and socio-economic indicators, for example health expenditure, which might suggest practical approaches for the reduction of vulnerability.

Dr Gianni Lo Iacono, Lecturer in Biostatistics and Epidemiology at the School of Veterinary Science at the University of Surrey, said: "The increasing danger of zoonotic diseases, such as Ebola and Lassa fever, has led to an urgent need to develop techniques to help public health practitioners evaluate how vulnerable populations are to epidemics.

"Recent outbreaks of Ebola in West Africa have shown the devastating and long lasting impact outbreaks of disease can have on populations. This model will help government and aid agencies identify regions that are struggling to cope with a disease outbreak."
-end-


University of Surrey

Related Ebola Articles:

Ebola survivors have a 'unique' retinal scar
Researchers from the University of Liverpool have conducted a study of Ebola survivors to determine if the virus has any specific effects on the back on the eye using an ultra widefield retinal camera.
Ebola: Lives to be saved with new management approach
Ebola outbreaks are set to be managed quickly and efficiently -- saving lives -- with a new approach developed by an international team of researchers, including the University of Warwick, which helps to streamline outbreak decision-making.
Ebola vaccines provide immune responses after 1 year
Immune responses to Ebola vaccines at one year after vaccination are examined in a new study appearing in the March 14 issue of JAMA.
New scoring system predicts Ebola severity
While Ebola virus disease (EVD) is notorious for being one of the world's most deadly infections, it actually has a wide range of outcomes, where asymptomatic presentation may be as common as fatality.
Could co-infection with other viruses affect the survival of those with Ebola virus?
Could co-infection with other viruses have a detrimental affect on Ebola survival, and why did some show Ebola symptoms without having the virus?
Antimalarial being tested as possible Ebola virus drug
The National Center for Advancing Translational Sciences (NCATS) recently awarded $596,533.00 to Collaborations Pharmaceuticals, Inc.
Ebola map may help prepare for future outbreaks
To be prepared for new Ebola virus disease cases, it is fundamental to start by identifying the range of the virus and the regions that are more favorable for its propagation.
Sexual transmission of Ebola likely to impact course of outbreaks
Sexual transmission of the Ebola virus could have a major impact on the dynamics of the disease, potentially reigniting an outbreak that has been contained by public health interventions, according to research by University of Georgia ecologists just published in the Royal Society journal Biology Letters.
Ebola vaccine: Promising phase I trials
The clinical phase I trial of a potential vaccine against the dreaded Ebola virus has been successfully completed at four partner sites in Africa and Europe.
Improving treatments for post-Ebola syndrome sufferers
Researchers from the University of Liverpool and the King's Sierra Leone Partnership are to present new findings into post-Ebola syndrome at a major European conference this week.

Related Ebola Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...